Armand P, Janssens AM, Gritti G, Radford J, et al. Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma. Blood 2020 Aug 31. pii: 463592. doi: 10.1182/blood.2019004753.
PMID: 32870269